EP Patent

EP3749301A1 — Pharmaceutical compositions for treating cystic fibrosis

Assigned to Vertex Pharmaceuticals Inc · Expires 2020-12-16 · 5y expired

What this patent protects

A pharmaceutical composition comprising Compound (I). Methods of treating cystic fibrosis comprising administering one or more of such pharmaceutial compositions to a patient.

USPTO Abstract

A pharmaceutical composition comprising Compound (I). Methods of treating cystic fibrosis comprising administering one or more of such pharmaceutial compositions to a patient.

Drugs covered by this patent

Patent Metadata

Patent number: EP3749301A1
Jurisdiction: EP
Classification: —
Expires: 2020-12-16
Drug substance claim: No
Drug product claim: No
Assignee: Vertex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.